105 related articles for article (PubMed ID: 32181542)
1. Targeting an Interaction Between Two Disordered Domains by Using a Designed Peptide.
Mayer G; Shpilt Z; Bressler S; Marcu O; Schueler-Furman O; Tshuva EY; Friedler A
Chemistry; 2020 Aug; 26(45):10240-10249. PubMed ID: 32181542
[TBL] [Abstract][Full Text] [Related]
2. Rational design using sequence information only produces a peptide that binds to the intrinsically disordered region of p53.
Kamagata K; Mano E; Itoh Y; Wakamoto T; Kitahara R; Kanbayashi S; Takahashi H; Murata A; Kameda T
Sci Rep; 2019 Jun; 9(1):8584. PubMed ID: 31253862
[TBL] [Abstract][Full Text] [Related]
3. Targeting Protein Interaction Hotspots Using Structured and Disordered Chimeric Peptide Inhibitors.
Mayer G; Shpilt Z; Kowalski H; Tshuva EY; Friedler A
ACS Chem Biol; 2022 Jul; 17(7):1811-1823. PubMed ID: 35758642
[TBL] [Abstract][Full Text] [Related]
4. A small peptide derived from p53 linker region can resume the apoptotic activity of p53 by sequestering iASPP with p53.
Qiu S; Cai Y; Gao X; Gu SZ; Liu ZJ
Cancer Lett; 2015 Jan; 356(2 Pt B):910-7. PubMed ID: 25444901
[TBL] [Abstract][Full Text] [Related]
5. Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.
Qiu S; Liu S; Yu T; Yu J; Wang M; Rao Q; Xing H; Tang K; Mi Y; Wang J
BMC Cancer; 2017 Nov; 17(1):795. PubMed ID: 29179704
[TBL] [Abstract][Full Text] [Related]
6. iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition.
Chen S; Wu J; Zhong S; Li Y; Zhang P; Ma J; Ren J; Tan Y; Wang Y; Au KF; Siebold C; Bond GL; Chen Z; Lu M; Jones EY; Lu X
Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17470-17479. PubMed ID: 31395738
[TBL] [Abstract][Full Text] [Related]
7. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins.
Ahn J; Byeon IL; Byeon CH; Gronenborn AM
J Biol Chem; 2009 May; 284(20):13812-13822. PubMed ID: 19246451
[TBL] [Abstract][Full Text] [Related]
8. 2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction.
Cheng HW; Chein RJ; Cheng TJ; Wu PS; Wu HY; Hung PF; Wang CJ; Hsu YL; Wong JM; Yuan A; Wong CH; Yang PC; Pan SH
Cancer Sci; 2018 Mar; 109(3):832-842. PubMed ID: 29285847
[TBL] [Abstract][Full Text] [Related]
9. Flexible Tethering of ASPP Proteins Facilitates PP-1c Catalysis.
Zhou Y; Millott R; Kim HJ; Peng S; Edwards RA; Skene-Arnold T; Hammel M; Lees-Miller SP; Tainer JA; Holmes CFB; Glover JNM
Structure; 2019 Oct; 27(10):1485-1496.e4. PubMed ID: 31402222
[TBL] [Abstract][Full Text] [Related]
10. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
12. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
13. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.
Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Suzuki F; Yamada T; Kudo M; Yue J; Sakuragi N
Sci Rep; 2016 Oct; 6():35480. PubMed ID: 27765948
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and expressions of apoptosis-related proteins p53, ASPP2 and iASPP in gastric cancer and precancerous lesions.
Meng WD; Chu RX; Wang BZ; Wang LP; Ma LL; Wang LX
Pathol Biol (Paris); 2013 Oct; 61(5):199-202. PubMed ID: 23528480
[TBL] [Abstract][Full Text] [Related]
15. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Shin JS; Ha JH; Chi SW
Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
[TBL] [Abstract][Full Text] [Related]
16. MiR-340/iASPP axis affects UVB-mediated retinal pigment epithelium (RPE) cell damage.
Yan J; Qin Y; Yu J; Peng Q; Chen X
J Photochem Photobiol B; 2018 Sep; 186():9-16. PubMed ID: 29982095
[TBL] [Abstract][Full Text] [Related]
17. Highly homologous proteins exert opposite biological activities by using different interaction interfaces.
Amir AI; van Rosmalen M; Mayer G; Lebendiker M; Danieli T; Friedler A
Sci Rep; 2015 Jul; 5():11629. PubMed ID: 26130271
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP.
Li S; Shi G; Yuan H; Zhou T; Zhang Q; Zhu H; Wang X
Oncol Rep; 2012 Jul; 28(1):133-40. PubMed ID: 22552744
[TBL] [Abstract][Full Text] [Related]
19. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2).
Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E
J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740
[TBL] [Abstract][Full Text] [Related]
20. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.
Bergamaschi D; Samuels Y; Sullivan A; Zvelebil M; Breyssens H; Bisso A; Del Sal G; Syed N; Smith P; Gasco M; Crook T; Lu X
Nat Genet; 2006 Oct; 38(10):1133-41. PubMed ID: 16964264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
